4Definitions

4 Definitions

Note: A number of expressions used in this instrument are defined in subsection 3(1) of the Act including:

(a) advertise;
(b) label;
(c) medical device;
(d) medicine;
(e) Register;
(f) supply;
(g) therapeutic use.

In this instrument:

Act means the Therapeutic Goods Act 1989.

AS 2896–2011 means the document, Australian Standard: Medical gas systems – Installation and testing of non-flammable medical gas pipeline systems (AS 2896–2011), prepared by Committee HE-017 (Medical Gas Systems), approved on behalf of the Council of Standards Australia on 13 January 2011, and published by SAI Global Limited under licence from Standards Australia on 8 May 2011, as in force or existing immediately before the commencement of this instrument.

AS/NZS 2604:2021 means the document Australian/New Zealand Standard AS/NZS 2604:2021, Sunscreen products ‑ Evaluation and classification, published jointly by, or on behalf of, Standards Australia and Standards New Zealand, as in force or existing on 1 July 2024.

haematopoietic progenitor cells has the meaning given by clause 1 of Part 1 of Schedule 9 to the Regulations.

health professional has the same meaning as in the Medical Devices Regulations.

Medical Devices Regulations means the Therapeutic Goods (Medical Devices) Regulations 2002.

Poisons Standard means the legislative instrument made under section 52D of the Act, as in force immediately before the commencement of this instrument.

Regulations means the Therapeutic Goods Regulations 1990.

secondary sunscreen product has the same meaning as in AS/NZS 2604:2021.

serious, for a condition, ailment or defect, has the same meaning as in the Medical Devices Regulations.

serious disease has the same meaning as in the Medical Devices Regulations.